Cell MedX Corp Performance
| CMXCDelisted Stock | USD 0.48 0.16 50.00% |
The firm shows a Beta (market volatility) of 38.65, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cell MedX will likely underperform. Cell MedX Corp right now shows a risk of 0.0%. Please confirm Cell MedX Corp total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Cell MedX Corp will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cell MedX Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cell MedX is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 45.1 K | |
| Total Cashflows From Investing Activities | -1574.00 | |
| Free Cash Flow | -562 K |
Cell |
Cell MedX Relative Risk vs. Return Landscape
If you would invest 48.00 in Cell MedX Corp on October 3, 2025 and sell it today you would earn a total of 0.00 from holding Cell MedX Corp or generate 0.0% return on investment over 90 days. Cell MedX Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Cell, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cell MedX Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cell MedX's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Cell MedX Corp, and traders can use it to determine the average amount a Cell MedX's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMXC |
Based on monthly moving average Cell MedX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cell MedX by adding Cell MedX to a well-diversified portfolio.
Cell MedX Fundamentals Growth
Cell OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cell MedX, and Cell MedX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cell OTC Stock performance.
| Return On Asset | -5.62 | |||
| Operating Margin | (297.67) % | |||
| Current Valuation | 1.91 M | |||
| Shares Outstanding | 62.92 M | |||
| Price To Earning | (5.25) X | |||
| Price To Sales | 591.58 X | |||
| Revenue | 6.76 K | |||
| EBITDA | (680.15 K) | |||
| Cash And Equivalents | 30.74 K | |||
| Total Debt | 343.67 K | |||
| Debt To Equity | (1.19) % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (560.43 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 52.24 K | |||
| Retained Earnings | (6.43 M) | |||
| Current Asset | 61.84 K | |||
| Current Liabilities | 21.6 K | |||
About Cell MedX Performance
By analyzing Cell MedX's fundamental ratios, stakeholders can gain valuable insights into Cell MedX's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cell MedX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cell MedX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinsons disease, high blood pressure, neuropathy, and kidney functions. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada. CELL MEDX operates under Medical Devices classification in the United States and is traded on OTC Exchange.Things to note about Cell MedX Corp performance evaluation
Checking the ongoing alerts about Cell MedX for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cell MedX Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cell MedX Corp is not yet fully synchronised with the market data | |
| Cell MedX Corp has some characteristics of a very speculative penny stock | |
| Cell MedX Corp has a very high chance of going through financial distress in the upcoming years | |
| Cell MedX Corp currently holds 343.67 K in liabilities. Cell MedX Corp has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cell MedX until it has trouble settling it off, either with new capital or with free cash flow. So, Cell MedX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cell MedX Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cell to invest in growth at high rates of return. When we think about Cell MedX's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 6.76 K. Net Loss for the year was (910.84 K) with loss before overhead, payroll, taxes, and interest of (39.05 K). | |
| Cell MedX Corp currently holds about 30.74 K in cash with (560.43 K) of positive cash flow from operations. | |
| Roughly 50.0% of the company shares are held by company insiders |
- Analyzing Cell MedX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cell MedX's stock is overvalued or undervalued compared to its peers.
- Examining Cell MedX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cell MedX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cell MedX's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cell MedX's otc stock. These opinions can provide insight into Cell MedX's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Cell OTC Stock
If you are still planning to invest in Cell MedX Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cell MedX's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |